Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Oncology|January 1, 1988
Long-term survival following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study Group TrialR T Chlebowski, S Nystrom, R Reynolds, et al.
Oncology|January 1, 1985
Cyclophosphamide plus 5-FU versus 5-FU alone in advanced gastric carcinomaR T Chlebowski, J M Weiner, I Silverberg, et al.
Breast Cancer Research and Treatment|December 1, 1989
Mitoxantrone use in breast cancer patients with elevated bilirubinR T Chlebowski, L Bulcavage, I C Henderson, et al.
Cancer|August 15, 1983
Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trialR T Chlebowski, R Pugh, J M Weiner, et al.
Cancer|May 1, 1980
Treatment of advanced colon cancer with 5-fluorouracil (NSC19893) versus cyclophosphamide (NSC26271) plus 5-fluorouracil: prognostic aspects of the differential white blood cell countR T Chlebowski, I Silverberg, T Pajak, et al.
Cancer Treatment Reports|November 1, 1979
Treatment of advanced gastric carcinoma with 5-fluorouracil: a randomized comparison of two routes of deliveryR T Chlebowski, W S Paroly, R P Pugh, et al.
Cancer|November 15, 1996
Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patientsM R Palomares, J W Sayre, K C Shekar, et al.
Cancer Research|October 1, 1992
Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patientsD P Rose, R T Chlebowski, J M Connolly, et al.
Oncology|January 1, 1987
Doxorubicin and methotrexate on a weekly schedule in patients with sarcomasR T Chlebowski, F Bull, L Irwin, et al.
Breast Cancer Research and Treatment|January 1, 1986
Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapyR T Chlebowski, J M Weiner, R Reynolds, et al.
Pageof 8